Ann: Quarterly Cashflow Report, page-23

I don’t post many, but I cant help but astonished that it was sold down to 0.06 !! Does Mr Market really comprehend the magnitude of this even ?

• $17M last QR..
• Production and Selling price increasing..
• FDA approval awaited..
• 12-15% growth expected even post pandemic..
• Targeting 220 Million per month production once the second plant commissioned in early 2022. 220 Million production @ USD 80 per 1000 pcs = USD 17.6 Million per MONTH !!

This looks like HT8 which I missed out the ride. Got in at the right time but then got frustrated when it was repeatedly capped down even after excellent results and sold out with loss and then it just blasted off. Missed the 7 bags ! Not going to miss out on this.. There is only so much they can cap this as it is no-brainer. Even current revenue of $17M per QTR is $68M AR and trading under that is ridiculous. Imminent re-rate…